Skip to main content
Fig. 6 | Respiratory Research

Fig. 6

From: Therapeutic effect of subcutaneous injection of low dose recombinant human granulocyte-macrophage colony-stimulating factor on pulmonary alveolar proteinosis

Fig. 6

Contrast of pulmonary function indexes (FVC, DLCO%) before and after treatment, FVC (a) improved after 6 months of treatment, and the difference was statistically significant. Seventeen patients were followed up after 12 months and 14 patients completed lung function examination, FVC was improved at 12 months compared with that before treatment, and the difference was not statistically significant. DLCO% (b) was also improved after treatment for 6 months, and the difference was statistically significant. Seventeen patients were followed up after 12 months, and 14 patients completed lung function examination, DLCO% was also improved at 12 months compared with that before treatment, and the difference was statistically significant

Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us